주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Thursday, March 28, 2024, 21:15
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
3 Celltrion Drugs Win Tenders by Public Organizations in Peru
Michael Herh
2024.02.16 13:59
Celltrion Achieves Successive Orders for Autoimmune Disease Similars in Europe
Jasmine Choi
2024.01.12 18:04
Integrated Celltrion to Launch: Global Big Pharma Firm with 12 Trillion Won Revenue
Choi Mun-hee
2023.12.28 09:09
Celltrion Healthcare’s Vegzelma Listed as Preferred Medicine in US Prescription Directories
Jung Min-hee
2023.12.13 15:52
[Celltrion Healthcare] Upward revision to 2024F earnings for merged Celltrion group
Pyeongkuk Park
2023.11.09 13:58
Is ‘Head-on Breakthrough’ Leadership of Celltrion’s Honorary Chairman Seo Jung-jin Now Facing Challenges?
Choi Mun-hee
2023.10.26 11:24
Celltrion Group Chairman Presents Group Vision to Foreign Investors in the US
Jasmine Choi
2023.09.12 17:51
Celltrion Obtains Sales Approval in Australia for Avastin Biosimilar 'Vegzelma'
Jasmine Choi
2023.09.04 22:15
Celltrion Completes Application for Stelara Biosimilar CT-P43 in Australia
Jasmine Choi
2023.09.01 15:32
Celltrion Group Begins Merger Procedure with Celltrion Healthcare
Jasmine Choi
2023.08.18 08:03
US Truxima price falls more than expected
Pyeongkuk Park
2023.07.17 18:39
New product effects exist, but 2Q23 results to disappoint
Pyeongkuk Park
2023.07.17 18:31
처음
1
2
다음
다음
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기